Phosphodiesterase-4 Inhibitors in the Treatment of Inflammatory Lung Disease

ISSN： 0012-6667

Source： Drugs, Vol.63, Iss.23, 2003-01, pp. : 2575-2594

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phosphodiesterase 4 Inhibitors in Inflammatory Bowel Disease: A Comprehensive Review

Current Pharmaceutical Design, Vol. 16, Iss. 33, 2010-11 ,pp. : 3661-3667

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase inhibitors in inflammatory bowel disease

By Salari Pooneh Abdollahi Mohammad

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 3, 2012-03 ,pp. : 261-264

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase 4 inhibitors for the treatment of asthma

By Karlsson J-A. Aldous D.

Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 9, 1997-09 ,pp. : 989-1003

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterase 4 Inhibitors for the Treatment of Asthma and COPD

Current Medicinal Chemistry, Vol. 13, Iss. 27, 2006-11 ,pp. : 3253-3262

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?

By Teixeira M.M. Gristwood R.W. Cooper N. Hellewell P.G.

Trends in Pharmacological Sciences, Vol. 18, Iss. 5, 1997-05 ,pp. : 164-170

Elsevier

Access to resources Recommend Favorite